Definition

  • Also known as “gluten sensitive enteropathy”
  • Common immune mediated malabsorptive condition
  • Abnormal response to Gliadin (component of Gluten)
  • Associated with flattening of the small intestinal villi

Incidence

  • Mainly European – 1/1000
  • (NB: Ireland 1/300)
  • Most common cause of malabsorption

Aetiology

  • Genetics
    • Immune disorder triggered by environmental agent (gluten) in predisposed individuals
  • Association with HLA-DQ2 & HLA-DQ8
    • Human Leukocyte Antigens
    • Convey susceptibility
    • Over 99% affected individuals have one of these
  • Risk Factors
    • Family history
    • 2-5% of 1st degree relatives develop symptomatic Coeliacs
    • Strong association with other auto-immune disorders
      • Type 1 DM
      • Autoimmune Thyroiditis
      • Also – Down Syndrome, Turner Syndrome, Pulmonary Haemosiderosis

Clinical Presentation

  • Childhood Presentation
    • Present at 1-2 yrs
    • Previously well then failure to thrive
    • May have
      • Diarrhoea
      • Irritability
      • Poor appetite
    • May have
      • Iron deficiency
      • Short stature
      • FHx
      • Abdo distension
      • Clubbing
  • Adult Presentation
    • Iron-deficiency
      • or combined Iron & Folate deficiency
    • Weight loss
    • Diarrhoea
    • Abdo discomfort (pain rare)
    • Borborygmi
    • Bloating
    • Associations:
      • Hyposplenism
      • Dermatitis Herpetiformis
        • “Coeliac Disease of the skin”
        • Vesicular, crusted, intensely pruritic lesions develop
        • Located on the back, buttocks, and elbows
        • Secondary infection common

Pathology

  • Involves an abnormal cellular (T-cell mediated) & humoral response to gliadin
  • Gliadin is a component of gluten (in wheat, barley), which acts as an epitope that the body reacts to
    • Causing mucosal damage
  • Get
    • Loss of brush border enzymes
    • Loss of stimulus for pancreatic & bile secretion
    • Low pancreozymin & secretin
    • Exudation of protein across denuded mucosa
    • Protein losing enteropathy

Histology

  • Macroscopically:
    • Mucosal Atrophy
    • Flattening of mucosal folds
    • Fissure, scalloping, prominent submucosal vascularity
  • Histological changes
    • Increased intra-epithelial lymphocytes
    • Villous atrophy / “clubbing”
    • Hypertrophy of crypts
    • Attempt to increase cell production

Normal A. Coeliac B

Complications

  • Increased risk for lymphoma and GI cancers
  • Uncertain whether compliance to gluten-free diet influences rate of cancer
  • Lymphoma the most common
  • GI cancers include
    • Oesophageal SCC
    • Small Intestine Adenocarcinoma
    • Colorectal
    • HCC
    • NB: Significantly reduced risk of Breast Cancer

Investigations

  • All testing for coeliac disease should be done when a patient is on a gluten-containing diet
  • If low probability, screen with serology first, if negative, stop
  • If high probability, do both serology and OGD
  • Serological blood tests
    • IgA anti-Tissue Transglutaminase antibody (anti-tTG)
      • Specific test, good NPV
    • IgA anti-Endomysial antibodies (EMA)
      • Highest diagnostic accuracy
      • Costly and not as widely available as anti-tTG
    • IgA & IgG anti-Gliadin antibodies (AGA)
      • IgA more specific (97%), but poor sensitivity (71%)
      • IgG less specific (87%) but more sensitive (87%)
  • Endoscopy – if positive serologic testing or high suspicion
    • To confirm the diagnosis
    • Need at least 4 x biopsies of post-bulbar duodenum

Management

  • Strict gluten-free diet
  • Avoid wheat, rye, and barley
  • NB: Oats are ok

Follow-up

  • Repeat biopsy at 3-4 months after dietary treatment
  • Check mucosal improvement